Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 35Carcinoma, Renal Cell 4Carcinoma, Hepatocellular 4Kidney Neoplasms 3Disease 3Neoplasms 2Breast Neoplasms 2Urogenital Neoplasms 1Prostatic Diseases 1Prostate Cancer Diagnosis 1Prostate Adenocarcinoma 1Pancreatic Neoplasms 1Neurilemmoma 1Neoplasms by Site 1Localized Prostate Cancer 1Liver Neoplasms 1Glioma 1Genital Neoplasms, Male 1Genital Diseases, Male 1Clear-cell metastatic renal cell carcinoma 1Castration Resistant Prostate Cancer 1Castrate Sensitive Prostate Cancer 1

Interventions

padeliporfin 4darolutamide 2apalutamide 2Abiraterone Acetate 2palladium-bacteriopheophorbide 1onapristone 1niraparib 1ixabepilone 1gedatolisib 1gallium 68 PSMA-11 1enzalutamide 1abiraterone 1Therapeutics 1Standard of Care 1Radiotherapy 1Prednisone 1Pluvicto 1Imatinib Mesylate 1EPI-506 1Docetaxel 1BAY 86-7548 1Androgen Antagonists 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1(225)Ac-PSMA-617 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genital Diseases, Male × 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid × Clear all
NCT04461509 2026-03-25

High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy

Cedars-Sinai Medical Center

Phase 2 Completed
62 enrolled 11 charts
Genitourinary

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡